- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03518346
Use of Virtual Reality Game Playing During Venipuncture
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will be randomly assigned using a random number generator to either the virtual reality condition, or to the standard procedure that includes using books and/or watching movies as a standard method of distraction.
Participants will take part in the study during their scheduled research venipuncture. The venipuncture lasts approximately 15-30 minutes. Pre and post venipuncture questionnaires for both participant and parent will take 15 minutes to complete. Total study time is between 30 and 45 minutes. Questionnaires completed by research personal will take 15 minutes to complete.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Sacramento, California, United States, 95817
- University of California Davis MIND Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants aged 8-19 years old that are receiving a blood draw as part of their ReCHARGE evaluation
- History of distress or refusal of blood draws or similar medical procedures OR
- Parent or child endorsement of fear, anxiety, concern or adherence in past blood draw during the recruitment phone call, consent or child evaluation will be offered the potential of the VR intervention OR
- Endorsement of anxiety or concerns with medical procedures on an in house phlebotomist blood draw screening form will also be used as inclusion criteria.
Exclusion Criteria:
- History of seizures.
- Vision loss or significant visual impairment to the degree that the participant is unable to see the activity and features of the VR game.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Virtual Reality Group
Participants may be randomized to the virtual reality, VR, group or the standard of care group.
For the VR group, we are using the Samsung VR Go (VR head set), Samsung S7 (phone) and programmed distraction (Spaceburgers, Pebbles the Penguin, and/or Happy Place).
Spaceburgers and Pebbles the Penguin were designed by the Department of Anesthesiology at Lucile Packard Children's Hospital Stanford through the Stanford Chariot Program (Childhood Anxiety Reduction Through Innovation and Technology).
Happy Place is a nongame immersive experience that will be offered to children uninterested in the previously mentioned game.
Happy Place was designed by a Swedish Pharmacy Chain, Apotek Hjartat, aimed to distract patients from their pain with a peaceful, interactive environment.
Each of the video games runs for the length of time needed to complete the venipuncture.
|
Samsung VR Go (VR head set), Samsung S7 (phone), and programmed distraction
|
Active Comparator: Standard of Care Group
Participants may be randomized to the virtual reality, VR, group or the standard of care group.
The standard of care group will use various distractions.
Distraction tools include books and movies using a wall mounted TV as standard practice.
|
Books, movies, TV
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Attempting vs. Refusing Venipuncture
Time Frame: 2 years
|
Compare if the participant is willing to let us attempt the venipuncture or refuses the venipuncture.
the number of patients will be counted.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood volume
Time Frame: 2 years. Collected once on each participant: immediately following injection
|
Volume of blood collected in mL
|
2 years. Collected once on each participant: immediately following injection
|
Pain Scale
Time Frame: 2 years. Collected once on each participant: immediately following injection
|
Pain scale measures patient reports of pain levels after venipuncture on scale of 0-10
|
2 years. Collected once on each participant: immediately following injection
|
Satisfaction Survey
Time Frame: 2 years. Collected once on each participant: immediately following injection
|
Child and Parent Satisfaction Survey consists of 5 questions with likert scale responses
|
2 years. Collected once on each participant: immediately following injection
|
Fear Scale
Time Frame: 2 years. Collected twice on each participant: before and immediately following injection
|
Child Fear scale measures patient reports of fear levels before and after venipuncture on scale of 0-4
|
2 years. Collected twice on each participant: before and immediately following injection
|
Time to Achieve Optimal Blood Volume
Time Frame: 2 years. Collected on each participant: during venipuncture procedure
|
Time in minutes
|
2 years. Collected on each participant: during venipuncture procedure
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1170355
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism
-
EarliTec Diagnostics, IncMarcus Autism CenterRecruitingAutism Spectrum Disorder | Developmental Delay | Autism | Autism, Early Infantile | Autism, InfantileUnited States
-
IRIS Media IncCompletedAutism DisorderUnited States
-
University of California, San FranciscoWithdrawn
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
Forest LaboratoriesMerz Pharmaceuticals GmbHCompletedAutism | Pediatric AutismUnited States
-
University of Medicine and Dentistry of New JerseyNational Alliance for Autism ResearchCompleted
-
General Administration of Military Health, TunisiaMilitary Hospital of TunisRecruiting
-
Assistance Publique - Hôpitaux de ParisUnknownAutism Spectrum Disorder | Child AutismFrance
-
The Hong Kong Polytechnic UniversityRecruitingAutism Spectrum Disorder | High-functioning AutismHong Kong
-
Emory UniversityNational Institute of Mental Health (NIMH)Terminated
Clinical Trials on Virtual Reality
-
Institut National de la Santé Et de la Recherche...Not yet recruitingSchizophrenia | Bipolar Disorder
-
Eskisehir Osmangazi UniversityNot yet recruiting
-
The University of Hong KongRecruiting
-
Universidad Rey Juan CarlosCompleted
-
University of PennsylvaniaNot yet recruitingEnd Stage Kidney Disease
-
National University of MalaysiaRecruitingPleural EffusionMalaysia
-
Stanford UniversityTerminatedConversion Disorder | Non-epileptic Seizures | Functional Neurological Disorder | Functional Movement Disorder | Psychogenic Movement DisorderUnited States
-
University of WashingtonNational Institutes of Health (NIH); University of Texas; National Institute...Completed
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la Loire; Gustave Roussy, Cancer Campus, Grand... and other collaboratorsTerminated
-
Hacettepe UniversityRecruitingGonarthrosis; PrimaryTurkey